AR080497A1 - Heterociclos radiomarcados con yodo,utiles para diagnosticar la enfermedad de alzheimer - Google Patents

Heterociclos radiomarcados con yodo,utiles para diagnosticar la enfermedad de alzheimer

Info

Publication number
AR080497A1
AR080497A1 ARP110100767A ARP110100767A AR080497A1 AR 080497 A1 AR080497 A1 AR 080497A1 AR P110100767 A ARP110100767 A AR P110100767A AR P110100767 A ARP110100767 A AR P110100767A AR 080497 A1 AR080497 A1 AR 080497A1
Authority
AR
Argentina
Prior art keywords
iodine
disease
useful
diagnosing alzheimer
radiomarced
Prior art date
Application number
ARP110100767A
Other languages
English (en)
Spanish (es)
Inventor
Heribert Schmitt
Tobias Heinrich
Damian Brockschnieder
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of AR080497A1 publication Critical patent/AR080497A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ARP110100767A 2010-03-11 2011-03-11 Heterociclos radiomarcados con yodo,utiles para diagnosticar la enfermedad de alzheimer AR080497A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10075112 2010-03-11

Publications (1)

Publication Number Publication Date
AR080497A1 true AR080497A1 (es) 2012-04-11

Family

ID=43969390

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100767A AR080497A1 (es) 2010-03-11 2011-03-11 Heterociclos radiomarcados con yodo,utiles para diagnosticar la enfermedad de alzheimer

Country Status (3)

Country Link
AR (1) AR080497A1 (zh)
TW (1) TW201134492A (zh)
WO (1) WO2011110511A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103724207B (zh) * 2013-12-20 2016-07-06 北京智博高科生物技术有限公司 苯基苄基醚类衍生物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27003A1 (es) * 2000-11-06 2002-07-31 Schering Ag Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
EP2163541A1 (en) * 2008-09-12 2010-03-17 Bayer Schering Pharma Aktiengesellschaft Piperazine derivatives for binding and imaging amyloid plaques and their use

Also Published As

Publication number Publication date
WO2011110511A1 (en) 2011-09-15
TW201134492A (en) 2011-10-16

Similar Documents

Publication Publication Date Title
AR071385A1 (es) Compuestos de 2-imino-3-metil pirrolopirimidinona sustituida con tiofenilo,composiciones farmaceuticas que los contienen,y uso de los mismos para el tratamiento de patologias asociadas con la proteina beta amiloide,tales como alzheimer y otros formas de demencia.
AR083760A1 (es) Agentes antibacterianos y composiciones farmaceuticas
MA38935B1 (fr) Dérivés de diazacarbazole à titre de ligands tau-pet
MA38540B1 (fr) Dérivés de naphtyridine utiles comme antagonistes de l'intégrine alpha-v-bêta-6
AR098912A1 (es) Inhibidores de syk
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
AR083849A1 (es) Antagonistas de mdm2 de espiro-oxindol
CR20140301A (es) Derivados de betulina
EA201100698A1 (ru) Производные тиенотриазолодиазепина, активные в отношении апо а1
MA35245B1 (fr) Pyridin-2-amides utiles comme agonistes de cb2
RU2016112547A (ru) Имидазо[1,2-а]пиридин-7-амины в качестве средств визуализации
AR070437A1 (es) Moduladores de beta - amiloide
MA35086B1 (fr) Compose de triazolopyridine
AR081426A1 (es) Derivados de pirazol inhibidores del receptor sigma
BR112014026266A2 (pt) derivado de quinazolidinadiona
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
RS53003B (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
ECSP12012290A (es) Formulaciones farmacéuticas
CR10842A (es) Derivados de acetileno y su uso para la union a placas amiloides y su diagnostico por imagenes
CO6251201A2 (es) Composiciones y metodos para el tratamiento de3 enfermedades y desordenes oftalmicos
EA200901142A1 (ru) 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
AR081893A1 (es) Derivados de acido 1-(2-fluorobifenil-4-il)-alquil carboxilico para la terapia de la amiloidosis transtiretina
AR065599A1 (es) Benzotiofenos y benzofuranos 2- heteroarilo sustituidos
CL2013003646A1 (es) Compuestos derivados de trans-1-(3s.1r)-6-cloro-3-fenilindan-1-il)-1,2,2-trimetilpiperazina deuterados, con actividad en los receptores 5ht2, d1 y d2; proceso de preparacion; compuesto intermediario; composicion y combinacion farmaceutica; y su uso para el tratamiento de la psicosis, entre otros.
BRPI0815129B8 (pt) composição radiofarmacêutica, e, métodos para preparação de uma composição radiofarmacêutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure